A 40-year-old man underwent liver transplantation for cirrhosis related to hepatitis B and C viruses in March 2001. Pneumonia and bacteremia with Klebsiella pneumoniae developed. Seven days after ...
One approach to understanding how orally administered drugs are absorbed and metabolized involves measuring compound concentrations in portal vein blood and in systemic circulation at various time ...
Portal vein blood flow accounts for 75% of total hepatic blood flow, with the hepatic artery accounting for the remainder. As a result, portal vein occlusion may have significant consequences for ...
The treatment of hepatocellular carcinoma with macrovascular invasion, including portal vein tumor thrombus, remains challenging to treat and has poor outcomes. Approximately 20% of patients with ...
Correlation of [68 Ga]Ga-PSMA-11 PET biodistribution with immunohistochemical PSMA expression in hepatocellular carcinoma: Results from the prospective study MORE-PSMA. This is an ASCO Meeting ...
Introduction: The prevalence and risk factors of portal vein thrombosis (PVT) are largely unclear, with an increasing number of studies reporting inconsistent results. Aim: The current study aimed to ...
The portal vein is responsible for collecting blood from the stomach, intestines, and spleen, and transporting it into the liver. However, in some cases, the lumen of the portal vein can become ...
Argon Medical Devices — a manufacturer of medical device solutions for interventional radiology, vascular surgery, interventional cardiology, and oncology — recently introduced its Traveler Portal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results